A Pay-for-Performance Initiative to Reduce Pediatric Psychiatric Inpatient Length of Stay.


Journal

Psychiatric services (Washington, D.C.)
ISSN: 1557-9700
Titre abrégé: Psychiatr Serv
Pays: United States
ID NLM: 9502838

Informations de publication

Date de publication:
01 02 2019
Historique:
pubmed: 6 11 2018
medline: 9 4 2020
entrez: 6 11 2018
Statut: ppublish

Résumé

This column presents results of a pay-for-performance (P4P) initiative to reduce psychiatric inpatient length of stay for Medicaid-covered youths at eight hospitals in Connecticut in 2008 (N=715), 2009 (N=1,408), and 2010 (N=782). Compared with the 2007 baseline, average length of stay decreased by 25% (from 18.1 to 13.6 days) by the end of the P4P program, with concurrent nonsignificant decreases in 7- and 30-day readmissions. Readmitted youths tended to access postdischarge care sooner and use more community-based services during the first 180 days postdischarge. Additional research is needed, but the P4P program appears to have contributed to shortening inpatient stay without apparent adverse outcome on increases in postdischarge service use.

Identifiants

pubmed: 30394181
doi: 10.1176/appi.ps.201800190
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

156-158

Auteurs

Timothy Schmutte (T)

Department of Psychiatry, Yale University, New Haven, Connecticut (Schmutte, Davidson); Beacon Health Options, Rocky Hill, Connecticut (Van der Heide, Szczygiel, Plant), and Boston (Phelan).

Laurie Van der Heide (L)

Department of Psychiatry, Yale University, New Haven, Connecticut (Schmutte, Davidson); Beacon Health Options, Rocky Hill, Connecticut (Van der Heide, Szczygiel, Plant), and Boston (Phelan).

Lori Szczygiel (L)

Department of Psychiatry, Yale University, New Haven, Connecticut (Schmutte, Davidson); Beacon Health Options, Rocky Hill, Connecticut (Van der Heide, Szczygiel, Plant), and Boston (Phelan).

Ann Phelan (A)

Department of Psychiatry, Yale University, New Haven, Connecticut (Schmutte, Davidson); Beacon Health Options, Rocky Hill, Connecticut (Van der Heide, Szczygiel, Plant), and Boston (Phelan).

Larry Davidson (L)

Department of Psychiatry, Yale University, New Haven, Connecticut (Schmutte, Davidson); Beacon Health Options, Rocky Hill, Connecticut (Van der Heide, Szczygiel, Plant), and Boston (Phelan).

Robert Plant (R)

Department of Psychiatry, Yale University, New Haven, Connecticut (Schmutte, Davidson); Beacon Health Options, Rocky Hill, Connecticut (Van der Heide, Szczygiel, Plant), and Boston (Phelan).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH